Skip to main content
Clinical Trials/NCT01687010
NCT01687010
Unknown
Not Applicable

Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.

Jianfeng Xie1 site in 1 country300 target enrollmentMarch 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diagnostic and Predictive Value
Sponsor
Jianfeng Xie
Enrollment
300
Locations
1
Last Updated
13 years ago

Overview

Brief Summary

Sepsis is a common cause for morbidity and mortality in critically ill patients. With the development of medical skills, the mortality is still remain very high. Inappropriateness of initial antibiotic treatment is an important risk factor for mortality and effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital discharge in adult patients with septic shock. However, the early treatment based on early diagnosis.But it is very difficult to diagnosis because of lack of specific clinic symptom and sign.When severe sepsis occur, biomarker could be helpful to diagnosis. Unfortunately, the diagnostic value of single biomarker is limited. Therefore, combine several biomarkers could enhance the diagnostic value.

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
October 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Jianfeng Xie
Responsible Party
Sponsor Investigator
Principal Investigator

Jianfeng Xie

Physician of critical care department

Southeast University, China

Eligibility Criteria

Inclusion Criteria

  • Critically ill patients admitted into ICU

Exclusion Criteria

  • Age younger than 18 years
  • Refuse to participate in this study

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials